Artificial Intelligence in Oncology: Clinical Applications, Challenges, and Opportunities
Artificial intelligence (AI) is reshaping cancer research and clinical oncology by enabling large-scale analysis of complex b [...]
Cost-effectiveness of an artificial intelligence predictive model for guiding androgen deprivation therapy in intermediate-risk prostate cancer
The ArteraAI Prostate Test (ArteraAI Inc.) is the first predictive biomarker for benefit of adding short-term androgen depriv [...]
Validation of Multimodal and Image-Only Artificial Intelligence Digital Pathology–Based Biomarkers Using Multi-Institutional, Real-World Data
Accurate risk stratification is essential to personalizing treatment decision-making in prostate cancer, enabling escalation [...]
Development and Validation of a Multimodal Artificial Intelligence–derived Digital Pathology–based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials
Biochemical recurrence (BCR) after radical prostatectomy (RP) is a heterogeneous disease state in prostate cancer with multip [...]
ASCO Oral Presentation
The STAMPEDE trials showed that adding abiraterone acetate + prednisolone (AAP) ± enzalutamide (ENZ) to standard of care andr [...]
External Validation of a Digital Pathology-Based Multimodal Artificial Intelligence-Derived Prognostic Model in Patients with Advanced Prostate Cancer Starting Long-term Androgen Deprivation Therapy
Effective prognostication improves selection of patients with prostate cancer for treatment combinations. We aimed to evaluat [...]
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III Trials
Artificial intelligence (AI) tools could improve clinical decision making or exacerbate inequities because of bias. African A [...]
Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials
Long-term androgen deprivation therapy (ADT) improves survival in men with high-risk localized prostate cancer (PCa) receivin [...]
Validation of a Digital Pathology–Based Multimodal Artificial Intelligence Biomarker in a Prospective, Real-World Prostate Cancer Cohort Treated with Prostatectomy
A multimodal artificial intelligence (MMAI) biomarker was developed using clinical trial data from North American men with lo [...]